The addition of the shKLK7+EGF group further validated that KLK7 may function as an upstream regulator of EMT, facilitating thyroid cancer cell metastasis by promoting the MAPK/ERK signaling pathway and coordinating the EMT process. The gene discussed is KLK7; the disease is thyroid cancer.